Ehret F, Abid FB, Ribeiro VT, Bodden R, Maluf FC, Larco-Castilla P, Naud LM, Ferraz de Paula Soares C, Shaikh E, Valente de Camargo L, Ridolfi FM. The IDEAL trial - a study protocol for a phase III randomized, double-blinded clinical trial assessing the ultra-short antibiotic prophylaxis of Isoniazid and Rifapentine in non-immunosuppressed patients with newly diagnosed latent tuberculosis. PPCR [Internet]. 2020 May 21 [cited 2024 Sep. 20];6(1):9-14. Available from: https://journal2.teste.pro.br/index.php/ppcrjournal/article/view/96